News & announcements
Every milestone in our work to widen access to advanced cancer care — newest first.
Showing 5 updates
May
CancerFax Partners with Global Oncology to Access China's Cancer Trial Network
CancerFax has entered into a working collaboration with Global Oncology, a leading clinical research organization in China. Direct access to one of the most active cancer trial ecosystems in the world — for patients who need it most.
CancerFax Team Visits Chula Cell and Gene Therapy Center in Bangkok
A CancerFax-led delegation visited the Chula Cell and Gene Therapy Center in Bangkok to learn first-hand about the progress in gene therapy for thalassemia — and what it means for patients and families waiting for better options.
January
VectorGene Biotech, Parent of CancerFax, Partners with the Chinese National Human Genome Center, Beijing
VectorGene Biotech Limited, the Hong Kong based parent company of CancerFax, has entered into a collaboration with the Chinese National Human Genome Center, Beijing (CHGB) and its translational arm IDTRI to bring advanced genomic testing, cell and gene therapy, and technology transfer programs to international hospitals, laboratories, and research partners.
CancerFax Establishes Strategic Partnership with RoyalLee Cancer Hospital in Guangzhou
RoyalLee Cancer Hospital in Guangzhou offers a focused range of advanced minimally invasive treatments for complex cancer cases. These include Yttrium-90 selective internal radiation therapy for liver tumors, argon-helium cryoablation for targeted tumor destruction using extreme cold, and nanoknife irreversible electroporation for cancers near critical structures where conventional ablation carries higher risk. Each treatment requires individual eligibility assessment based on cancer type, stage, tumor location, and overall patient condition.